Jefferies analyst Stephen Barker downgraded PeptiDream to Hold from Buy with a price target of 1,900 yen, down from 2,200 yen. The analyst has become more optimistic about the company’s radiopharma revenues, but less optimistic about margins.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PPTDF: